SEC Form 4 · accession 0001567619-18-001687
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Richard
Director
Period of report
Aug 3, 2018
Accepted (ET)
Aug 23, 2018 · 8:51 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 3, 2018 | M | 100 | $14.71 | A | 21,063 | D | |
| Common StockF1 | Aug 3, 2018 | S | 100 | $60.00 | D | 20,963 | D | |
| Common StockF1 | Aug 21, 2018 | M | 7,793 | $14.71 | A | 28,756 | D | |
| Common StockF1,F2 | Aug 21, 2018 | S | 7,793 | $60.0166 | D | 20,963 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3,F4 | $14.71 | Aug 3, 2018 | M | 100 | D | — | May 19, 2020 | Common Stock | 100 | 7,793 | D |
| Stock Option (Right to Bury)F3,F4 | $14.71 | Aug 21, 2018 | M | 7,793 | D | — | May 19, 2020 | Common Stock | 7,793 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to 60.05, inclusive.
- F3Consists of an option granted under the company's stock incentive plan as amended and restated.
- F4The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.